Molecular Staging

company

About

Molecular Staging is a life sciences tool company, develops technologies for the detection and measurement of proteins and nucleic acids.

  • 101 - 250

Details

Last Funding Type
Series D
Last Funding Money Raised
$41.30M
Industries
Biotechnology,Pharmaceutical
Founded date
Jan 1, 1998
Number Of Employee
101 - 250
Operating Status
Active

Molecular Staging, Inc., a life sciences tool company, develops technologies for the detection and measurement of proteins and nucleic acids. It provides technologies for proteomics, genomics, pharmacogenomics, and diagnostics applications. The company’s products and services include protein microarrays analogous to the DNA microarray, enabling researchers to study multiple proteins; whole-genome amplification that allows DNA samples as resources, enabling researchers to return to them for new tests or confirmatory diagnoses; and multiplexed diagnostics that enable earlier detection of disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$41.30M
Molecular Staging has raised a total of $41.30M in funding over 2 rounds. Their latest funding was raised on Dec 19, 2000 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 19, 2000 Series D $41.30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Molecular Staging is funded by 1 investors. Cooper Hill Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Cooper Hill Partners Series D